Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia [1]

European Journal of Haematology

Volumn 75, Issue 6, 2005, Pages 527-529

  Nishio, Mitsufumi ^a   Endo, Tomoyuki ^a   Fujimoto, Katusya ^a   Sato, Norihiro ^b   Sakai, Toshiya ^a   Obara, Masato ^a   Kumano, Koti ^a   Minauchi, Koichiro ^a   Koike, Takao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD27 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; PREDNISOLONE; RITUXIMAB; TACROLIMUS; VINCRISTINE; VIRUS DNA;

ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; BACTERIAL INFECTION; CASE REPORT; CELL LOSS; CHRONIC GRAFT VERSUS HOST DISEASE; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOELECTROPHORESIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; MEMORY CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; SEPSIS;

AGAMMAGLOBULINEMIA; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; LYMPHOMA, AIDS-RELATED; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDNISONE; TRANSPLANTATION, HOMOLOGOUS; VINCRISTINE;

EID: 28044455650     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00552.x     Document Type: Letter

References (10)

1. MILES SA, MCGRATTEN M. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma. J Clin Oncol 2005;23:247-248.
2. IMASHUKU S, TERAMURA T, MORIMOTO A, NAYA M, KURODA H. Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein-Barr virus-associated lymphoproliferative disease. Bone Marrow Transplant 2004;33:129-130.
3. VERSCHUUREN EA, STEVENS SJ, VAN IMHOFF GW, et al. Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation 2002;73:100-104.
4. HORWITZ SM, NEGRIN RS, BLUME KG, et al. Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood 2004;103:777-783.
5. SHIMONI A, HARDAN I, AVIGDOR A, et al. Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma. Br J Haematol 2003;122:457-464.
6. NISHIO M, NAKAO S, ENDO T, et al. Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure. Bone Marrow Transplant 2001;28:783-785.
7. ENDO T, NAKAO S, KOIZUMI K, et al. Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient. Ann Hematol 2004;83:114-116.
8. PIQUERAS B, LAVENU-BOMBLED C, GALICIER L, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003;23:385-400.
9. MALONEY DG, GRILLO-LOPEZ AJ, WHITE CA, et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997;90:2188-2195.
10. KUEHNLE I, HULS MH, LIU Z, et al. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood 2000;95:1502-1505.